These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 36306202)

  • 1. Distant metastases in human papillomavirus-related oropharyngeal squamous cell carcinoma: Systematic review and meta-analysis.
    Crossley JR; Nelson LL; Chou J; Maxwell JH
    Head Neck; 2023 Jan; 45(1):275-282. PubMed ID: 36306202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic evaluation and meta-analysis of the prognosis of down-staging human papillomavirus (HPV) positive oropharyngeal squamous cell carcinoma using cetuximab combined with radiotherapy instead of cisplatin combined with radiotherapy.
    Hu Q; Li F; Yang K
    PeerJ; 2024; 12():e17391. PubMed ID: 38784388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcomes of oropharyngeal squamous cell carcinoma stratified by human papillomavirus subtype: A systematic review and meta-analysis.
    Shenker RF; Razavian NB; D'Agostino RB; Mowery YM; Brizel DM; Hughes RT
    Oral Oncol; 2024 Jan; 148():106644. PubMed ID: 38006690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global prevalence of human papillomavirus-related oral and oropharyngeal squamous cell carcinomas: a systematic review and meta-analysis.
    Fonsêca TC; Jural LA; Marañón-Vásquez GA; Magno MB; Roza ALOC; Ferreira DMTP; Maia LC; Romañach MJ; Agostini M; Abrahão AC
    Clin Oral Investig; 2023 Dec; 28(1):62. PubMed ID: 38158517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterizing distant metastases and survival in oropharyngeal squamous cell carcinoma.
    Saiyed FK; Guo T; Johnson F; Myers JN
    Head Neck; 2021 Jul; 43(7):2101-2109. PubMed ID: 33738875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of reduced- versus standard-dose radiotherapy on survival and radiation-associated toxicity in patients with human papillomavirus-associated oropharyngeal squamous cell carcinoma: a systematic review protocol.
    Lee TJ; Krishnan G; Ooi EH; Barker TH
    JBI Evid Synth; 2022 Apr; 20(4):1135-1141. PubMed ID: 34698708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility of clinical evaluation of individuals with increased risk for HPV-associated oropharynx cancer.
    Scott-Wittenborn N; D'Souza G; Aygun N; Tewari SR; Azadi J; Vosler P; Gooi Z; Mehta V; Mydlarz W; Nance M; Mlot S; Patel MR; Tan M; Miles BA; Troy T; Fakhry C
    Head Neck; 2023 Jan; 45(1):95-102. PubMed ID: 36200696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic Delay in Human Papillomavirus Negative Oropharyngeal Squamous Cell Carcinoma.
    Karp EE; Yin LX; O'Byrne TJ; Lu LY; Routman DM; Lester SC; Neben Wittich MA; Ma DJ; Price KA; Chintakuntlawar AV; Tasche KK; Price DL; Moore EJ; Van Abel KM
    Laryngoscope; 2023 Jun; 133(6):1394-1401. PubMed ID: 35851669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the capacity of methylated DNA markers of cervical squamous cell carcinoma to discriminate oropharyngeal squamous cell carcinoma in human papillomavirus mediated disease.
    Bartemes KR; Gochanour BR; Routman DM; Ma DJ; Doering KA; Burger KN; Foote PH; Taylor WR; Mahoney DW; Berger CK; Cao X; Then SS; Haller TJ; Larish AM; Moore EJ; Garcia JJ; Graham RP; Bakkum-Gamez JN; Kisiel JB; Van Abel KM
    Oral Oncol; 2023 Nov; 146():106568. PubMed ID: 37717549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Significance of the Microenvironment in Human Papillomavirus Oropharyngeal Carcinoma: A Systematic Review.
    Baudouin R; Hans S; Lisan Q; Morin B; Adimi Y; Martin J; Lechien JR; Tartour E; Badoual C
    Laryngoscope; 2024 Apr; 134(4):1507-1516. PubMed ID: 37642393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papillomavirus co-infection and survival in oral and oropharyngeal squamous cell carcinoma: A study in 235 Brazilian patients.
    Silveira HA; Almeida LY; Carlos R; Silva EV; Ferrisse TM; Duarte A; Cardoso SCS; Polanco XBJ; Bufalino A; Ribeiro-Silva A; León JE
    Auris Nasus Larynx; 2022 Apr; 49(2):258-270. PubMed ID: 34274177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Incidence, Survival, and HPV Impact of Second Primary Cancer following Primary Oropharyngeal Squamous Cell Carcinoma: A 20-Year Retrospective and Population-Based Study.
    Andersen L; Jakobsen KK; Carlander AF; Garset-Zamani M; Friborg J; Kiss K; Marvig RL; Olsen C; Nielsen FC; Andersen E; Grønhøj C; Buchwald CV
    Viruses; 2022 Dec; 15(1):. PubMed ID: 36680074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of human papillomavirus on patterns of distant metastatic failure in oropharyngeal squamous cell carcinoma treated with chemoradiotherapy.
    Trosman SJ; Koyfman SA; Ward MC; Al-Khudari S; Nwizu T; Greskovich JF; Lamarre ED; Scharpf J; Khan MJ; Lorenz RR; Adelstein DJ; Burkey BB
    JAMA Otolaryngol Head Neck Surg; 2015 May; 141(5):457-62. PubMed ID: 25742025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How to prevent human papillomavirus-related oropharyngeal cancer?
    Ferrando-Díez A; Pavón MA; Cirauqui B; Alemany L; Mesía R
    Curr Opin Oncol; 2023 May; 35(3):145-150. PubMed ID: 36966500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus, oropharyngeal cancer, and the latest vaccine: considerations for oral healthcare providers.
    Watt M; Li E; Closmann J; Chang O
    Gen Dent; 2024; 72(3):74-77. PubMed ID: 38640011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of human papillomavirus status on prognosis and local treatment strategies of T1-2N0 oropharyngeal squamous cell cancer.
    Zhou P; Chen DL; Lian CL; Wu SG; Zhang SY
    Front Public Health; 2022; 10():900294. PubMed ID: 35958856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic review on location and timing of distant progression in human papillomavirus-positive and human papillomavirus-negative oropharyngeal squamous cell carcinomas.
    Tiedemann D; Jakobsen KK; von Buchwald C; Grønhøj C
    Head Neck; 2019 Mar; 41(3):793-798. PubMed ID: 30582231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The evolving landscape of human papillomavirus-related oropharyngeal squamous cell carcinoma at a single institution in Northern Italy.
    Morbini P; Alberizzi P; Ferrario G; Capello G; De Silvestri A; Pedrazzoli P; Tinelli C; Benazzo M
    Acta Otorhinolaryngol Ital; 2019 Feb; 39(1):9-17. PubMed ID: 30936574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. De-intensified adjuvant (chemo)radiotherapy versus standard adjuvant chemoradiotherapy post transoral minimally invasive surgery for resectable HPV-positive oropharyngeal carcinoma.
    Howard J; Dwivedi RC; Masterson L; Kothari P; Quon H; Holsinger FC
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012939. PubMed ID: 30550641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Papillomavirus Impact on Temporal Treatment Trends in Oropharyngeal Carcinoma: 2010-2016.
    Amin N; Thompson J; Goloubeva O; Witek M; Taylor RJ; Wolf JS; Moyer K; Mehra R; Hatten KM
    ORL J Otorhinolaryngol Relat Spec; 2022; 84(6):438-446. PubMed ID: 36067748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.